Thursday 19 February 2026

One To Watch

Auven Therapeutics

Company Overview

Want to Update your Company's Profile?


Latest Auven Therapeutics News

ADC Therapeutics and BZL Biologics sign antibody agreement
15 July 2013
More Auven Therapeutics news >


Today's issue

Positive billing but Ocular’s Axpaxli data disappoints investors
Pharmaceutical
Positive billing but Ocular’s Axpaxli data disappoints investors
18 February 2026
Pharmaceutical
Novartis’ remibrutinib closes in on further urticaria indication
18 February 2026
Pharmaceutical
Recordati delivers solid year, with more to come in 2026
18 February 2026
Biotechnology
Unnatural Products strikes up to $1.7B partnership with Novartis
18 February 2026
Biosimilars
Sandoz wins expanded US FDA approval for Enzeevu
18 February 2026
Biotechnology
FDA to initiate review of Moderna seasonal flu vaccine submission
18 February 2026
Biotechnology
Korsana Biosciences emerges with $175 million funding
18 February 2026


Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze